Industry Advocacy

The next most important issues are creating greater transparency in generic prescription drug reimbursements and the inclusion of an any willing pharmacy provision for Medicare Part D plans.

The Association for Accessible Medicines and the National Association of Chain Drug Stores are lobbying Congress and the White House for a change in the Centers for Medicare and Medicaid Services’ policy on reimbursement for biosimilar medicines

NACDS Retail Advisory Board looks to lend strategy assist. Many associations — including NACDS — were created in part to foster an ecosystem, where businesses can maximize their performance through collaboration.

In this special report, DSN takes a look at the collaborative solutions the industry is undertaking to keep patients safe as deaths from opioid abuse and misuse continue to rise.

Four health systems — Salt Lake City-based Intermountain Healthcare, alongside Ascension, SSM Health and Trinity Health — are coming together to create a nonprofit generic drug company in consultation with the Department of Veterans Affairs.

Kroger's new head of government relations and regulatory affairs will be based in Washington, D.C.

The current OTC regulatory framework is based on a 45-year-old model that requires notice and comment rulemaking.

Is this where we are headed? Will other retailers soon join 7/11, the nation’s largest convenience store chain, and become worried about federal immigration agents showing up, unannounced, and carting away undocumented workers and demanding paperwork from store managers to prove otherwise?